BioMimetic Therapeutics , Nasdaq: BMTI
Develops bio-active drug-device combination products for musculoskeletal injuries.
Industry: Health Care
First Day Return: +3.1%
Industry: Health Care
BMTI
Develops bio-active drug-device combination products for musculoskeletal injuries.
| IPO Data | |
|---|---|
| IPO File Date | 02/10/2006 |
| Offer Price | $8.00 |
| Price Range $11.00 - $13.00 | |
| Offer Shares (mm) | 4.6 |
| Deal Size ($mm) | $37 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 05/11/2006 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $37 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Franklin, TN, United States |
| Founded | 1999 |
| Employees at IPO | 41 |
| Website www.biomimetics.com | |
IPO News for BioMimetic Therapeutics
BioMimetic Therapeutics (BMTI) Performance
